Evidence map›Paper›PMID 42010087›Full record

ArticleWorld journal of microbiology & biotechnology2026

Laser ablation synthesis Au@NiO nanoparticles: a new frontier in broad-spectrum antibacterial nanomaterials.

Eman M Sulaiman, Mohammed W Muayad, Ahmed B Taha, Falah A H Mutlak, Majid S Jabir, Uday M Nayef, Dunya K Rashid

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eman M SulaimanComputer Engineering College, University of Technology, Baghdad, Iraq.
Mohammed W MuayadRenewable Energy Research Center - Kirkuk, Northern Technical University, Mosul, Iraq. mohammed.muayad25@ntu.edu.iq.
Ahmed B TahaDepartment of Physics, College of Science, University of Baghdad, Baghdad, Iraq.
Falah A H MutlakDepartment of Physics, College of Science, University of Baghdad, Baghdad, Iraq.
Majid S JabirDepartment of Biotechnology, College of Applied Sciences, University of Technology, Baghdad, Iraq.
Uday M NayefDepartment of Physics, College of Applied Sciences, University of Technology, Baghdad, Iraq.
Dunya K RashidCollege of Nursing, University of Kirkuk, Kirkuk, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of drug resistance has driven extensive efforts to create new antimicrobial nanomaterials capable of killing both Gram-negative and Gram-positive bacteria through different mechanisms. Here, we report the synthesis and antibacterial activity of Au, NiO, and core–shell Au@NiO nanoparticles (NPs), highlighting the synergistic interaction at the plasmonic metal/p-type semiconductor interface. The nanostructures were characterized physicochemically, and their antibacterial efficacy against Streptococcus mutans and Pseudomonas aeruginosa was tested using the agar well diffusion method. Quantitative data showed that Au@NiO NPs had the strongest antibacterial effect, with inhibition zones measuring 17.68 mm for S. mutans and 14.16 mm for P. aeruginosa larger than those of NiO NPs (13.39 mm and 11.10 mm) or Au NPs (10.95 mm and 9.85 mm), respectively. The mechanistic study indicates that the bactericidal activity is improved in two ways by the Au(core)–NiO(shell) structure: (1) the edge effect of the Au/NiO heterojunction promotes efficient separation and generation of ROS, and (2) the hydroxylated surface of the NiO shell encourages adhesion to bacterial cell membranes. This combined approach is especially effective at penetrating bacterial defenses, such as the thick peptidoglycan layer in Gram-positive bacteria and the lipopolysaccharide outer membrane in Gram-negative bacteria. These findings present a promising strategy for designing next-generation broad-spectrum antimicrobial nanostructures for use in biomedical coatings, oral care, and environmental disinfection.

Indexed as

Anti-Bacterial AgentsGoldMetal NanoparticlesNickelLasersMicrobial Sensitivity TestsPseudomonas aeruginosaReactive Oxygen SpeciesStreptococcus mutansAnti-Bacterial AgentsGoldNickelnickel monoxideReactive Oxygen SpeciesAntibacterial activityAntimicrobial nanomaterialsAu@NiO nanoparticlesSynergistic mechanism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.